Good news for HIV/AIDS sufferers:


THE search for an Aids vaccine took an important step forward yesterday when scientists said that they had mapped the structure of an antibody that can neutralise the virus.
Research in the United States has revealed why an immune molecule called 2G12, first isolated from an Aids patient a decade ago, binds to HIV and prevents it from infecting human cells.